Cite

HARVARD Citation

    Gougelet, A. et al. (2016). Antitumour activity of an inhibitor of miR-34a in liver cancer with β-catenin-mutations. Gut. 65 (6), pp. 1024-1034. [Online]. 
  
Back to record